Drugplain

PROPOLIS NASAL PLUS 15.21 mg/30mL

PLUS NASAL · LIQUID · SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI

No Recall History
Plain English

PROPOLIS NASAL PLUS is a liquid containing plus nasal at 15.21 mg/30mL, taken nasal. Manufactured by SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI.

Key Facts

Brand Name
PROPOLIS NASAL PLUS
Generic Name
PLUS NASAL
NDC Code (Product)
82123-021
Manufacturer
SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI
Strength
15.21 mg/30mL
Dosage Form
LIQUID
Route
NASAL
Marketing Status
Application #
M012
Marketing Start
10/03/2023

Recall History

No Recall History

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Use Hand Sanitizer to help reduce bacteria that potentially can cause disease. For use when soap and water are not available.

Dosage & Administration

Directions Place enough product on hands to cover all surfaces. Rub hands together until dry. Supervise children under 6 years of age when using this product to avoid swallowing.

Warnings

Warnings For external use only. Flammable. Keep away from heat or flame

Frequently Asked Questions

What is PROPOLIS NASAL PLUS used for?

PROPOLIS NASAL PLUS contains PLUS NASAL. It is a liquid taken nasal. Consult your doctor for specific uses.

Is PROPOLIS NASAL PLUS a controlled substance?

PROPOLIS NASAL PLUS is not classified as a controlled substance by the DEA.

What is the generic name for PROPOLIS NASAL PLUS?

The generic name for PROPOLIS NASAL PLUS is PLUS NASAL. There are no other listed brand versions of PLUS NASAL.

What is the NDC code for PROPOLIS NASAL PLUS 15.21 mg/30mL?

The NDC (National Drug Code) for PROPOLIS NASAL PLUS 15.21 mg/30mL is 82123-021, listed by SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI.

Product NDC

82123-021

Package NDC

82123-021-31

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)